TREA

Matthew Arnold Marx

Follow

Person

  • San Diego, CA, US
People

Patents Grantslast 30 patents

  • Information Patent Grant

    Tetrahydropyridopyrimidine pan-KRas inhibitors
    • Patent number 11,999,753
    • Issue date Jun 4, 2024
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12D inhibitors
    • Patent number 11,964,989
    • Issue date Apr 23, 2024
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 11,932,633
    • Issue date Mar 19, 2024
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    SOS1 inhibitors
    • Patent number 11,702,418
    • Issue date Jul 18, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 11,548,888
    • Issue date Jan 10, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    MTA-cooperative PRMT5 inhibitors
    • Patent number 11,492,351
    • Issue date Nov 8, 2022
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
    • Patent number 11,485,738
    • Issue date Nov 1, 2022
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    MTA-cooperative PRMT5 inhibitors
    • Patent number 11,479,551
    • Issue date Oct 25, 2022
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Grant

    KRas G12D inhibitors
    • Patent number 11,453,683
    • Issue date Sep 27, 2022
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRAS G12C inhibitors
    • Patent number 11,267,812
    • Issue date Mar 8, 2022
    • Mirati Therapeutics, Inc.
    • John P. Fischer
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
    • Patent number 11,220,509
    • Issue date Jan 11, 2022
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
    • Patent number 11,091,495
    • Issue date Aug 17, 2021
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 10,689,377
    • Issue date Jun 23, 2020
    • Mirati Therapeutics, Inc.
    • James F. Blake
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 10,647,715
    • Issue date May 12, 2020
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 10,633,381
    • Issue date Apr 28, 2020
    • Mirati Therapeutics, Inc.
    • James F. Blake
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    EZH2 inhibitors
    • Patent number 10,266,542
    • Issue date Apr 23, 2019
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    LSD1 inhibitors
    • Patent number 10,233,152
    • Issue date Mar 19, 2019
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    KRas G12C inhibitors
    • Patent number 10,125,134
    • Issue date Nov 13, 2018
    • Mirati Therapeutics, Inc.
    • James F. Blake
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    LSD1 inhibitors
    • Patent number 10,059,668
    • Issue date Aug 28, 2018
    • Mirati Therapeutics, Inc.
    • Arkadii Vaisburg
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Grant

    LSD1 inhibitors
    • Patent number 9,809,541
    • Issue date Nov 7, 2017
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20240309020
    • Publication date Sep 19, 2024
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20240228510
    • Publication date Jul 11, 2024
    • Aaron Craig Burns
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MTA-Cooperative PRMT5 Inhibitors
    • Publication number 20240208912
    • Publication date Jun 27, 2024
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20240101553
    • Publication date Mar 28, 2024
    • Mirati Therapeutics, Inc.
    • Matthew Arnold MARX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20240034733
    • Publication date Feb 1, 2024
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    QUINAZOLINE PAN-KRas INHIBITORS
    • Publication number 20240025907
    • Publication date Jan 25, 2024
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20230373999
    • Publication date Nov 23, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold MARX
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20230357277
    • Publication date Nov 9, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20230339976
    • Publication date Oct 26, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SOS1 INHIBITORS
    • Publication number 20230312482
    • Publication date Oct 5, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20230279025
    • Publication date Sep 7, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SUBSTITUTED IMIDAZO[1,2-c]PYRIMIDINES AS PRC2 INHIBITORS
    • Publication number 20230137025
    • Publication date May 4, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SOS1 INHIBITORS
    • Publication number 20230137886
    • Publication date May 4, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SOS1 INHIBITORS
    • Publication number 20230101312
    • Publication date Mar 30, 2023
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    Azaquinazoline pan-KRas inhibitors
    • Publication number 20230072276
    • Publication date Mar 9, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12D INHIBITORS
    • Publication number 20230077225
    • Publication date Mar 9, 2023
    • Mirati Therapeutics, Inc.
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MTA-Cooperative PRMT5 Inhibitors
    • Publication number 20230054883
    • Publication date Feb 23, 2023
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    IMIDAZO[1,2-C]PYRIMIDINE DERIVATIVES AS PRC2 INHIBITORS FOR TREATIN...
    • Publication number 20220274990
    • Publication date Sep 1, 2022
    • Mirati Therapeutics, Inc.
    • Matthew Arnold MARX
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS
    • Publication number 20220213097
    • Publication date Jul 7, 2022
    • Mirati Therapeutics, Inc.
    • John Michael KETCHAM
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    TETRAHYDROPYRIDOPYRIMIDINE PAN-KRAS INHIBITORS
    • Publication number 20220194961
    • Publication date Jun 23, 2022
    • Xiaolun Wang
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20210380570
    • Publication date Dec 9, 2021
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20210269432
    • Publication date Sep 2, 2021
    • Mirati Therapeutics, Inc.
    • John P. FISCHER
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20210230170
    • Publication date Jul 29, 2021
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
  • Information Patent Application

    PRC2 INHIBITORS
    • Publication number 20210230168
    • Publication date Jul 29, 2021
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    SOS1 INHIBITORS
    • Publication number 20210188857
    • Publication date Jun 24, 2021
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PRC2 INHIBITORS
    • Publication number 20210101904
    • Publication date Apr 8, 2021
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    MTA-Cooperative PRMT5 Inhibitors
    • Publication number 20210079003
    • Publication date Mar 18, 2021
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
  • Information Patent Application

    MTA-Cooperative PRMT5 Inhibitors
    • Publication number 20210078994
    • Publication date Mar 18, 2021
    • Mirati Therapeutics, Inc.
    • Thomas P. Bobinski
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    PRC2 Inhibitors
    • Publication number 20210032252
    • Publication date Feb 4, 2021
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • C07 - ORGANIC CHEMISTRY
  • Information Patent Application

    KRAS G12C INHIBITORS
    • Publication number 20200331911
    • Publication date Oct 22, 2020
    • Mirati Therapeutics, Inc.
    • Matthew Arnold Marx
    • A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE